NCT04851119 2026-02-24
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05838716 2026-01-15
ViPER
University of Rochester
Phase 3 Recruiting
NCT05876923 2025-11-10
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Mayo Clinic
Phase NA Recruiting
NCT07044310 2025-07-29
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Mayo Clinic
Phase 2 Recruiting